Zobrazeno 1 - 5
of 5
pro vyhledávání: '"E. A. Jain (Korsakova)"'
Autor:
E. A. Gaidai, K. L. Kryshen, E. A. Jain (Korsakova), D. V. Demchenko, D. R. Kargopol’tseva, A. E. Katel’nikova, D. S. Gaidai, V. Yu. Balabanyan
Publikováno v:
Вопросы вирусологии, Vol 66, Iss 4, Pp 279-288 (2021)
Introduction. Combination antiretroviral therapy is currently the main component of treatment for human immunodeficiency virus (HIV) infected patients. At the same time, the high mutational potential of the virus and the frequency of side effects of
Externí odkaz:
https://doaj.org/article/5784ac81188d4761aeb5a06ad0f80af9
Autor:
V. A. Vavilova, E. V. Shekunova, E. A. Jain (Korsakova), V. Yu. Balabanyan, A. A. Ozerov, M. N. Makarova, V. G. Makarov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 9, Iss 3, Pp 205-221 (2021)
Antiretroviral therapy is currently the main component of treatment for HIV patients. The development of new, more effective and safer drugs is an urgent task.The aim of the research is to study the toxic properties of the finished dosage form (FDF)
Externí odkaz:
https://doaj.org/article/00b483770bed417c9042497a896b0dd4
Autor:
E. A. Jain (Korsakova), D. V. Demchenko, A. A. Ozerov, M. N. Makarova, V. G. Makarov, V. Yu. Balabanyan
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 9, Iss 2, Pp 114-129 (2021)
The aim of the study is to identify 1-[2-(2-benzoylphenoxy) ethyl]-6-methyluracil using various methods of analysis, as well as to study its action mechanism against wild-type and mutant forms of HIV-1 reverse transcriptase (RT).Materials and methods
Externí odkaz:
https://doaj.org/article/27a11791bdbf4fa09cb4df5843a2846a
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 2, Pp 106-111 (2021)
Introduction. The study of pharmacokinetics of medicinal substances and evaluation of their pharmacokinetic parameters is a necessary stage of pharmaceutical development of original medicinal agents, allowing to choose the composition and dosage form
Externí odkaz:
https://doaj.org/article/39dfeef83f364a40a0c54937654a0673
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 9, Iss 4, Pp 79-87 (2020)
Introduction. 1-[2-(2-benzoylphenoxy)ethyl]-6-methyluracil is a substance of scientific interest intended for the treatment of HIV-infection. However, its low bioavailability is a major limitation in successful drug delivery by oral route. Therefore,
Externí odkaz:
https://doaj.org/article/572e6de2c8f44d85b3c5636eb8e69b88